NOVT vs XENE

Comparison between Novanta Inc (NOVT, Company) and Xenon Pharmaceuticals Inc (XENE, Company).

NOVT is from the Technology sector, while XENE is from the Healthcare sector.

5-Year PerformanceXENE has outperformed NOVT, delivering a return of +27.7% compared to +1.3%

NOVT vs XENE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	NOVT(COMPANY)	XENE(COMPANY)
Market Cap	$5.83B	$5.83B
Max Drawdown	46.71%	90.43%
Sharpe Ratio	0.61	1.19
5Y Beta	1.60	0.93
Industry	Scientific & Technical Instruments	Biotechnology
P/E Ratio	108.81	-12.96
Forward P/E	8.39	N/A
PEG Ratio	2.11	-0.32
5Y EPS CAGR	3.84%	40.27%
Debt to Equity	18.41%	0.00%
Free Cash Flow Yield	1.18%	-5.27%
P/S Ratio	5.80	727.44
P/B Ratio	4.45	4.36

Market Cap

Winner

NOVT

$5.83B

XENE

$5.83B

Max Drawdown

Winner

NOVT

46.71%

XENE

90.43%

Sharpe Ratio

NOVT

0.61

Winner

XENE

1.19

5Y Beta

NOVT

1.60

Winner

XENE

0.93

Industry

NOVT

Scientific & Technical Instruments

XENE

Biotechnology

P/E Ratio

NOVT

108.81

Winner

XENE

-12.96

Forward P/E

NOVT

8.39

XENE

N/A

PEG Ratio

NOVT

2.11

Winner

XENE

-0.32

5Y EPS CAGR

NOVT

3.84%

Winner

XENE

40.27%

Debt to Equity

NOVT

18.41%

Winner

XENE

0.00%

Free Cash Flow Yield

Winner

NOVT

1.18%

XENE

-5.27%

P/S Ratio

Winner

NOVT

5.80

XENE

727.44

P/B Ratio

NOVT

4.45

Winner

XENE

4.36

NOVT vs XENE - Historical Returns

Returns include dividend reinvestment.

Period	NOVT	XENE
1 month	-10.03%	+23.75%
3 months	+28.25%	+9.92%
6 months	+18.97%	+50.45%
1 year	+14.79%	+99.09%
5 years(CAGR)	+1.30%	+27.73%
10 years(CAGR)	+25.61%	+24.65%
Max(CAGR)	+25.84%	+16.66%

NOVT

-10.03%

Winner

XENE

+23.75%

Winner

NOVT

+28.25%

XENE

+9.92%

NOVT

+18.97%

Winner

XENE

+50.45%

NOVT

+14.79%

Winner

XENE

+99.09%

5Y(CAGR)

NOVT

+1.30%

Winner

XENE

+27.73%

10Y(CAGR)

Winner

NOVT

+25.61%

XENE

+24.65%

Max(CAGR)

Winner

NOVT

+25.84%

XENE

+16.66%

NOVT vs XENE - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

Year	NOVT	XENE
2026	+33.03%	+42.44%
2025	-21.16%	+11.58%
2024	-7.02%	-12.71%
2023	+24.91%	+23.62%
2022	-21.81%	+24.82%
2021	+49.84%	+111.94%
2020	+29.17%	+12.10%
2019	+38.01%	+96.26%
2018	+24.75%	+119.48%
2017	+132.02%	-64.01%
2016	+58.85%	-3.27%
2015	N/A	-57.01%
2014	N/A	+88.10%

NOVT vs XENE Drawdown Comparison

The maximum drawdown for NOVT was -46.71%, occurring on Nov 20, 2025. This drawdown has not yet recovered.

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The current NOVT drawdown is -20.60%.

Rank	NOVT	XENE
#1	-46.71% Jul 16, 2024 - Nov 20, 2025	-90.43% Jan 8, 2015 - Oct 4, 2021
#2	-38.60% Nov 4, 2021 - Jun 29, 2023	-43.59% Feb 9, 2024 - Mar 9, 2026
#3	-34.98% Jul 17, 2023 - Jul 16, 2024	-34.08% May 9, 2023 - Dec 22, 2023
#4	-31.80% Feb 13, 2020 - May 20, 2020	-30.14% Nov 5, 2021 - Aug 4, 2022
#5	-27.81% Aug 27, 2018 - Feb 22, 2019	-25.87% Nov 11, 2014 - Dec 11, 2014
#6	-24.96% Jun 28, 2019 - Jan 13, 2020	-18.40% Mar 9, 2026 - Jul 7, 2026
#7	-19.00% Nov 21, 2017 - Jan 16, 2018	-17.08% Mar 1, 2023 - May 3, 2023
#8	-18.56% Jan 26, 2018 - Apr 17, 2018	-16.98% Aug 24, 2022 - Feb 13, 2023
#9	-16.09% Aug 6, 2020 - Oct 9, 2020	-11.44% Oct 15, 2021 - Nov 2, 2021
#10	-15.54% Feb 12, 2021 - Aug 11, 2021	-11.09% Dec 11, 2014 - Dec 29, 2014
#11	-11.81% Jun 5, 2020 - Aug 6, 2020	-9.36% Feb 13, 2023 - Mar 1, 2023
#12	-11.56% Apr 12, 2019 - Jun 18, 2019	-8.58% Jan 8, 2024 - Feb 8, 2024
#13	-11.54% Jun 14, 2018 - Jul 20, 2018	-8.27% Aug 10, 2022 - Aug 24, 2022
#14	-11.40% Jan 5, 2016 - Mar 4, 2016	-6.08% Dec 29, 2014 - Jan 7, 2015
#15	-11.16% Sep 24, 2021 - Oct 22, 2021	-4.89% Dec 27, 2023 - Jan 8, 2024